Ras Signalling in Human Melanoma
人类黑色素瘤中的 Ras 信号转导
基本信息
- 批准号:7061472
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Most human melanomas of the superficial spreading and nodular clinical subtypes contain activating mutations in either the NRAS small GTPase or the BRAF protein kinase. To determine the possible functional consequences of the molecular heterogeneity of human melanomas, we have begun to characterize the set of signalling pathways stimulated by RAS in both categories of human melanomas. We hypothesize that NRAS melanomas may exhibit activation of additional, RAS-dependent signalling pathways than BRAF melanomas. As such, alternative RAS-dependent signalling pathways may be relevant as molecular targets for human melanoma, at least for that class of human melanomas exhibiting activating mutations in NRAS.
大多数浅表扩散型和结节型临床亚型的人类黑色素瘤在NRAS小GT激酶或BRAF蛋白激酶中含有激活突变。为了确定人类黑色素瘤的分子异质性的可能的功能后果,我们已经开始表征在两类人类黑色素瘤中由RAS刺激的信号通路的集合。我们假设NRAS黑色素瘤可能比BRAF黑色素瘤表现出额外的RAS依赖性信号通路的激活。因此,替代RAS依赖性信号传导途径可能与人黑素瘤的分子靶标相关,至少对于表现出NRAS激活突变的那类人黑素瘤而言。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
mark udey其他文献
mark udey的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('mark udey', 18)}}的其他基金
相似海外基金
The mechanism of oral carcinogenesis by FAT1 gene mutation
FAT1基因突变导致口腔癌的机制
- 批准号:
23K15977 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an efficient method combining quantum chemistry and machine learning to evolve PCR technology and gene mutation analysis
开发一种结合量子化学和机器学习的有效方法来发展 PCR 技术和基因突变分析
- 批准号:
22KJ2450 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of preemptive medicine for asymptomatic MEN1 gene mutation carriers
无症状MEN1基因突变携带者的抢先治疗药物开发
- 批准号:
23H03151 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidation of molecular mechanisms of occurrence of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
23K08067 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the molecular mechanism of maxillofacial hypoplasia caused by FAT1 gene mutation
FAT1基因突变引起颌面发育不全的分子机制阐明
- 批准号:
22K19629 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Association between CD79B gene mutation and prognosis in vitreoretinal lymphoma
CD79B基因突变与玻璃体视网膜淋巴瘤预后的关系
- 批准号:
22K09763 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene mutation/expression prediction from clinical images using artificial intelligence technology in pancreatic cancer
利用人工智能技术从临床图像预测胰腺癌基因突变/表达
- 批准号:
20K17570 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of colorectal carcinogenesis mediated by PTPRK gene mutation
PTPRK基因突变介导的结直肠癌发生机制的阐明
- 批准号:
20K16311 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the molecular mechanism of development of anaplastic thyroid cancer using gene mutation analysis and comprehensive gene expression analysis
利用基因突变分析和综合基因表达分析阐明甲状腺未分化癌发生的分子机制
- 批准号:
20K08953 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of next-generation precision medicine targeting the pathways on which driver gene mutation-positive lung cancer depends
针对驱动基因突变阳性肺癌所依赖的途径开发下一代精准医疗
- 批准号:
20H03771 - 财政年份:2020
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Scientific Research (B)